Phase 1 Safety and Tolerability Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Completed

Phase 1

A Single dose safety and tolerability study of oral noribogaine in healthy volunteers

Safety and tolerability study of oral noribogaine in Healthy Volunteer Participants

DemeRx, Inc.36 enrolled1 locationACTRN12612000821897

Recruiting

Phase 1

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of KDF-07002 in Healthy, Adult Volunteers

This trial is to assess safety and tolerability of KDF-07002 in healthy adult males and dose not focus on any particular health condition or problem

Nucleus Network, Ltd.54 enrolled1 locationACTRN12609000086268

Completed

Phase 1

Phase Ia Pharmacokinetic and Tolerability Study of Oral NV-27 in Normal Healthy Volunteers

Safety and tolerability of the investigational drug NV-27 in healthy male volunteers

Novogen Research Pty Ltd6 enrolled1 locationACTRN12607000611426